The properties of known drugs. 1. Molecular frameworks
- PMID: 8709122
- DOI: 10.1021/jm9602928
The properties of known drugs. 1. Molecular frameworks
Abstract
In order to better understand the common features present in drug molecules, we use shape description methods to analyze a database of commercially available drugs and prepare a list of common drug shapes. A useful way of organizing this structural data is to group the atoms of each drug molecule into ring, linker, framework, and side chain atoms. On the basis of the two-dimensional molecular structures (without regard to atom type, hybridization, and bond order), there are 1179 different frameworks among the 5120 compounds analyzed. However, the shapes of half of the drugs in the database are described by the 32 most frequently occurring frameworks. This suggests that the diversity of shapes in the set of known drugs is extremely low. In our second method of analysis, in which atom type, hybridization, and bond order are considered, more diversity is seen; there are 2506 different frameworks among the 5120 compounds in the database, and the most frequently occurring 42 frameworks account for only one-fourth of the drugs. We discuss the possible interpretations of these findings and the way they may be used to guide future drug discovery research.
Similar articles
-
A scoring scheme for discriminating between drugs and nondrugs.J Med Chem. 1998 Aug 27;41(18):3325-9. doi: 10.1021/jm9706776. J Med Chem. 1998. PMID: 9719584
-
[Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].Yao Xue Xue Bao. 2008 Mar;43(3):227-33. Yao Xue Xue Bao. 2008. PMID: 18630256 Chinese.
-
In silico screening of drug databases for TSE inhibitors.Biosystems. 2005 May;80(2):117-22. doi: 10.1016/j.biosystems.2004.10.004. Biosystems. 2005. PMID: 15823410
-
Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.Bioinformatics. 2005 May 15;21(10):2145-60. doi: 10.1093/bioinformatics/bti314. Epub 2005 Feb 15. Bioinformatics. 2005. PMID: 15713739 Review.
-
'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.Drug Discov Today. 2009 Jan;14(1-2):31-40. doi: 10.1016/j.drudis.2008.10.011. Epub 2008 Dec 26. Drug Discov Today. 2009. PMID: 19049901 Review.
Cited by
-
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.J Med Chem. 2012 Jul 26;55(14):6582-94. doi: 10.1021/jm300687e. Epub 2012 Jul 5. J Med Chem. 2012. PMID: 22716043 Free PMC article.
-
A solution-phase parallel synthesis of alkylated guanidines from thioisocyanates and amines.Mol Divers. 2013 Aug;17(3):471-7. doi: 10.1007/s11030-013-9444-z. Epub 2013 May 1. Mol Divers. 2013. PMID: 23636682
-
Medicinal Chemistry Strategies for the Modification of Bioactive Natural Products.Molecules. 2024 Feb 2;29(3):689. doi: 10.3390/molecules29030689. Molecules. 2024. PMID: 38338433 Free PMC article. Review.
-
Synthetic strategies to terpene quinones/hydroquinones.Mar Drugs. 2012 Feb;10(2):358-402. doi: 10.3390/md10020358. Epub 2012 Feb 14. Mar Drugs. 2012. PMID: 22412807 Free PMC article. Review.
-
Structural and Activity Profile Relationships Between Drug Scaffolds.AAPS J. 2015 May;17(3):609-19. doi: 10.1208/s12248-015-9737-5. Epub 2015 Feb 20. AAPS J. 2015. PMID: 25697829 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical